Is your Medical Practice Website Design a Success or a Failure?
Why you need a New Website Design? What can make a website a popular visitor's haven while another website suffers from poor traffic? Is it just the design, or is it the content, or is there any other element at work here? Even to the untrained eye, the look, feel, and general layout of a website matters; what the website can offer by way of reader value also matters. The design of your healthcare practice website, content appeal, social media…
  • Latest Ideas

  • Things you can do to Enhance Patient Loyalty
    Most marketers agree that one existing customer is better than two new ones. A patient who is loyal to a medical practice will spread the good word about the practice and be responsible for bringing several new patients to the practice over time. Making efforts to win patient loyalty will always be rewarded in more ways than what a doctor or a medical marketer can imagine. It pays to focus on building patient loyalty by way of improved and personalized…
  • Latest Think Like an Entrepreneur Articles

  • October 2014

    Online Reputation Management — Is your Practice On-board?
  • Latest Videos

  • MELA Sciences Names Michael R. Stewart Its Next President and CEO
    MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, a non-invasive software-driven image analysis device approved for use in the U.S. and the European Union to assist dermatologists in melanoma diagnosis, today announced that its Board of Directors has named Michael R. Stewart, 57, as the company's next President and Chief Executive Officer, effective December 15.Read Full Article
  • Latest Newswire Stories

  • FDA Approves New Topical Gel Treatment for Acne Vulgaris
    Valeant Pharmaceuticals International, Inc. announced today that the US Food and Drug Administration (FDA) has approved Onextron (clindamycin phosphate and benzoyl peroxide), 1.2%/3.75%, topical gel for the once-daily treatment of comedonal (non-inflammatory) and inflammatory acne in patients 12 and older. According to Valeant, Onextron Gel is “the first and only FDA-approved fixed combination 1.2% clindamycin phosphate.Read Full Article
  • Latest Clinical Articles